Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma

Published 2022 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma
Authors
Keywords
-
Journal
BLOOD
Volume 140, Issue Supplement 1, Pages 7174-7175
Publisher
American Society of Hematology
Online
2022-11-29
DOI
10.1182/blood-2022-169971

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.